Key Points The transaction involved shares equal to 2% of the stake held before the filing. The executive retains direct ownership of approximately 304,000 shares following the completion of the sale. This transaction was executed under a Rule 10b5-1 trading plan, indicating the sale was part of a pre-scheduled portfolio management strategy. 10 stocks we like better than Hims & Hers Health › Chief Legal Officer Soleil Boughton reported a sale of 6,236 shares of Hims & Hers Health (NYSE:HIMS) in a recent SEC Form 4 filing . Transaction summary Transaction value based on SEC Form 4 weighted average sale price ($27.86); post-transaction value based on Sept. 16, 2026, market close ($28).
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.
